Global Blood Therapeutics Prices A $100.0 Million Common Stock Public Offering
December 15, 2017 at 09:49 AM EST
Global Blood Therapeutics, Inc. today announced the pricing of its underwritten public offering of its common stock for gross proceeds of approximately $100.0 million.